Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, December 18, 2014
Technology Networks
 
Register | Sign in
Home Page>Latest Webcasts

  Webcasts

Scientific News
Closing in on ‘Holy Grail’ of HIV Vaccine
Researchers describe a way to induce long-sought broadly neutralizing antibodies.
Parkinson's Vaccine: EU-Team Launches Clinical Trial
Vaccine candidate based on proprietary technology by AFFiRiS AG.
Injectable 3-D Vaccines Could Fight Cancer
New findings show programmable biomaterials can be delivered using needle injection to induce an immune response and fight deadly diseases.
Booster Ebola Vaccine Enters First Trials
Trials aim to determine the safety of a candidate booster vaccine.
Breast Cancer Vaccine Shows Promise In Small Clinical Trial
A breast cancer vaccine designed by researchers at Washington University School of Medicine in St. Louis is safe in patients with metastatic breast cancer.
NIAID/GSK Experimental Ebola Vaccine Appears Safe, Prompts Immune Response
Results from NIH Phase 1 clinical trial support accelerated development of candidate vaccine.
A Hybrid Vehicle That Delivers DNA
University at Buffalo researchers are developing new technology to improve DNA vaccines. The new transport system for DNA vaccines could help treat HIV, malaria, HPV and other major illnesses.
Themis Bioscience’s Vaccine Against Chikungunya Successful in Phase 1
Results presented at international conferences in Philadelphia and New Orleans.
Novel Cancer Vaccine Approach for Brain Tumors
Researchers unravel the mechanisms behind a novel cancer vaccine for brain tumors, paving the way for further development.
Computer Model Sets New Precedent in Drug Discovery
New computational model can precisely simulate, predict therapeutic protein behaviors to help zero in on ideal drug design candidates.

Glycosylation of IgG antibodies: a Critical Quality Attribute (CQA)
Professor Roy Jefferis, College of Medical and Dental Sciences, University of Birmingham, speaking at BioProcessing, Biologics & Biotherapeutics Congress 2011.

Continuous Chromatography (MCSGP) for the Purification of Therapeutic Proteins
Dr Thomas Müller-Späth, ETH Switzerland, speaking at BioProcessing, Biologics & Biotherapeutics Congress 2011.

Biosimilars and the US-legislation: Analytical and Clinical Challenges
Dr William Egan, Vice President in the Consulting Division of PharmaNet, speaking at BioProcessing, Biologics & Biotherapeutics Congress 2011.

Actionable Biomarkers for Rheumatoid Arthritis
Dr William Robinson, Stanford University, speaking at Microarray World Congress 2011.

Background and Key Drivers Leading to Clinical Immunogenicity
Dr Matthew Baker, Chief Scientific Officer at Antitope Ltd, speaking at Bioprocessing, Biologics and Biotherapeutics 2011.

Thinking Small so as to Gain the Bigger Picture: Progress in High Throughput Bioprocess Development
Professor Nigel Titchener-Hooker, University College London, speaking at Bioprocessing, Biologics and Biotherapeutics Congress 2011.

Antibody Fragments - New Approaches for Production
Dr John Lidell, FujiFilm, speaking at BioProcessing, Biologics & Biotherapeutics Congress 2011.

EU Regulatory Landscape for Approval of Biosimilars
Dr Lincoln Tsang, Arnold and Porter LLP, speaking at BioProcessing, Biologics & Biotherapeutics Congress / Stem Cells Europe 2011.

Modeling and Prediction of Antibody Chromatography Purification
Professor Christian Frech, Mannheim University of Applied Science, speaking at BioProcessing, Biologics and Biotherapeutics Congress.

<< 1 2 3 4 >>
Showing Results 21 - 30 of 31
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn